Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy.
about
An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 linkThe conundrum of causality in tumor virology: the cases of KSHV and MCVEpstein-Barr Virus: Diseases Linked to Infection and TransformationDenis Burkitt and the African lymphomaIntroducing mediterranean journal of hematology and infectious diseases.Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene BimViral response to chemotherapy in endemic burkitt lymphomaEpstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2ABurkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features.Latent Epstein-Barr virus can inhibit apoptosis in B cells by blocking the induction of NOXA expressionMicrogeographic variations in Burkitt's lymphoma incidence correlate with differences in malnutrition, malaria and Epstein-Barr virusLymphomas differ in their dependence on Epstein-Barr virusEtiopathogenesis of Burkitt's lymphoma: a lesson from a BL-like in CD1 mouse immune to Plasmodium yoelii yoelii.A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphomaEarly age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma.Clinical course and prognostic factors of children with Burkitt's lymphoma in a developing country: the experience of a single centre in BrazilImmune escape by Epstein-Barr virus associated malignancies.Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers detected by xMAP technology.Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.Advances in the understanding of MYC-induced lymphomagenesis.Why do viruses cause cancer? Highlights of the first century of human tumour virology.EBV primary infection in childhood and its relation to B-cell lymphoma development: a mini-review from a developing region.Epstein-Barr virus and Burkitt lymphoma.Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1.Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature.Burkitt lymphoma in African children: a priority for the global health agenda?EBV interferes with the sensitivity of Burkitt lymphoma Akata cells to etoposide.Cancer of childhood in sub-Saharan Africa.Epstein-Barr virus (EBV) association and latency profile in pediatric Burkitt's lymphoma: experience of a single institution in Argentina.c-Myc and cancer metabolism.Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study.EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
P2860
Q21131584-B3CDDC4C-AB54-4669-8088-D747BBDF31D7Q26863112-761CF18A-7750-4A77-A665-39D0F5FC7DA8Q28074586-C80F4307-2091-4E09-BBCF-21F7AF4B38D8Q28742252-8D6E1B8C-C5C1-40A6-B45D-D5ED701BE4F8Q30484888-245B81A4-6720-40C5-A7E0-2143AEDFAB46Q33474807-DF6804D6-1ACF-43C8-BDC7-0801E94FB903Q33767066-628E6397-A280-4A71-8449-567446C8E936Q33794029-446CE962-5939-4CA2-BD06-0FB891F1E633Q33835215-B7D5AA46-D4CF-4B8D-B9E3-7C51928163C0Q34103135-988ABEB9-B63E-4C08-BA9F-7234AC979B0EQ34363449-C3D67C91-5447-4309-BCE5-B35FF173C5A0Q34667776-15FFB221-CB0B-4F08-B21F-5942AD11D586Q35166501-D85171D5-0225-4868-91E1-83D777F79D4EQ35631310-8E1AA089-9BCB-407C-8036-57A93083EF83Q35766015-501BB1C9-4071-4825-8EAD-CCD28A7D325DQ36364844-6DEB6E0D-48A0-461C-828F-F327CA8EF04DQ37041507-F183EE2F-BDD6-4037-B952-FA215E1D3734Q37325545-E9E3BF58-19EF-482E-B690-4327303CA5AEQ37394390-3A42B6AD-EF0E-46CB-88A3-07F0C029D1B6Q37719736-7DBE819A-8F49-41C8-B4D8-25D261311A0BQ37811898-BAE19C02-078C-484B-BE31-B9A851CCA836Q38045798-B2AE2E42-233A-4E56-AB21-BBD8B0CA5695Q38270680-9702A3F6-6D1D-435B-83AD-17456F88F6ABQ38631755-8E968E4D-3AC4-4E23-8FE0-16343E27FC04Q39220424-438F0EE3-399F-456F-BE0C-83714B4C49DCQ39396356-E404365C-9951-47C2-83B7-68BBCC0329ECQ39633184-1C76C6E7-3D9F-44BF-AD4A-5759C5894827Q40050081-A3F5541A-7478-4E16-9D05-BCE9A5C31D5DQ42270362-E002666A-DCB0-4BB1-B5FF-D7BDE29FAC9CQ42351696-FDA6FE44-D52E-4252-810E-4693A0EC92FBQ44393910-9846CE48-613E-4815-9C42-452FC130CD6EQ47117102-6B26176F-56B5-4A60-BD33-3812B5088548
P2860
Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy.
@en
Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy.
@nl
type
label
Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy.
@en
Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy.
@nl
prefLabel
Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy.
@en
Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy.
@nl
P1476
Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy.
@en
P2093
Alan B Rickinson
Gemma L Kelly
P304
P356
10.1182/ASHEDUCATION-2007.1.277
P577
2007-01-01T00:00:00Z